137 related articles for article (PubMed ID: 9203216)
1. Prenatal diagnosis of a deletion of 18q in a fetus associated with multiple-marker screen positive results.
Chen CP; Chern SR; Liu FF; Jan SW; Lee CC; Chang YC; Yue CT
Prenat Diagn; 1997 Jun; 17(6):571-6. PubMed ID: 9203216
[TBL] [Abstract][Full Text] [Related]
2. Prenatal diagnosis of de novo t(2;18;14)(q33.1;q12.2;q31.2), dup(5)(q34q34), del(7)(p21.1p21.1), and del(10)(q25.3q25.3) and a review of the prenatally ascertained de novo apparently balanced complex and multiple chromosomal rearrangements.
Chen CP; Chern SR; Lee CC; Lin CC; Li YC; Hsieh LJ; Chen WL; Wang W
Prenat Diagn; 2006 Feb; 26(2):138-46. PubMed ID: 16470734
[TBL] [Abstract][Full Text] [Related]
3. Multiple marker screening test: identification of fetal cystic hygroma, hydrops, and sex chromosome aneuploidy.
Wenstrom KD; Boots LR; Cosper PC
J Matern Fetal Med; 1996; 5(1):31-5. PubMed ID: 8796763
[TBL] [Abstract][Full Text] [Related]
4. A retrospective evaluation of maternal serum screening for the detection of fetal aneuploidy.
Suzumori K; Tanemura M; Murakami I; Okada S; Natori M; Tanaka M; Takagi T; Sato A
Prenat Diagn; 1997 Sep; 17(9):861-6. PubMed ID: 9316131
[TBL] [Abstract][Full Text] [Related]
5. Preliminary evidence for associations between second-trimester human chorionic gonadotropin and unconjugated oestriol levels with pregnancy outcome in Down syndrome pregnancies.
Benn PA
Prenat Diagn; 1998 Apr; 18(4):319-24. PubMed ID: 9602476
[TBL] [Abstract][Full Text] [Related]
6. Prenatal diagnosis of the distal 11q deletion and review of the literature.
Chen CP; Chern SR; Chang TY; Tzen CY; Lee CC; Chen WL; Chen LF; Wang W
Prenat Diagn; 2004 Feb; 24(2):130-6. PubMed ID: 14974122
[TBL] [Abstract][Full Text] [Related]
7. Triploidy identified through second-trimester serum screening.
Huang T; Alberman E; Wald N; Summers AM
Prenat Diagn; 2005 Mar; 25(3):229-33. PubMed ID: 15791661
[TBL] [Abstract][Full Text] [Related]
8. hCG and the free beta-subunit as screening tests for Down syndrome.
Knight GJ; Palomaki GE; Neveux LM; Fodor KK; Haddow JE
Prenat Diagn; 1998 Mar; 18(3):235-45. PubMed ID: 9556040
[TBL] [Abstract][Full Text] [Related]
9. Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free beta-hCG and PAPP-A at 11 + 0 to 13 + 6 weeks.
Falcon O; Auer M; Gerovassili A; Spencer K; Nicolaides KH
Ultrasound Obstet Gynecol; 2006 Feb; 27(2):151-5. PubMed ID: 16388509
[TBL] [Abstract][Full Text] [Related]
10. [Maternal serum alpha-fetoprotein as a screening test for fetal Down syndrome].
Bessho T; Kanazawa R; Shiotani T; Mitsuo M; Koyama K
Nihon Sanka Fujinka Gakkai Zasshi; 1995 Mar; 47(3):237-43. PubMed ID: 7535328
[TBL] [Abstract][Full Text] [Related]
11. Prenatal diagnosis of partial monosomy 18p(18p11.2-->pter) and trisomy 21q(21q22.3-->qter) with alobar holoprosencephaly and premaxillary agenesis.
Chen CP; Chern SR; Wang W; Lee CC; Chen WL; Chen LF; Chang TY; Tzen CY
Prenat Diagn; 2001 May; 21(5):346-50. PubMed ID: 11360273
[TBL] [Abstract][Full Text] [Related]
12. Triploid partial molar pregnancy detected through maternal serum alpha-fetoprotein and HCG screening.
Harper MA; Ruiz C; Pettenati MJ; Rao PN
Obstet Gynecol; 1994 May; 83(5 Pt 2):844-6. PubMed ID: 7512706
[TBL] [Abstract][Full Text] [Related]
13. Combining beta-core fragment and total oestriol measurements to test for Down syndrome pregnancies.
Cole LA; Acuna E; Isozaki T; Palomaki GE; Bahado-Singh RO; Mahoney MO
Prenat Diagn; 1997 Dec; 17(12):1125-33. PubMed ID: 9467809
[TBL] [Abstract][Full Text] [Related]
14. Down syndrome: prenatal risk assessment and diagnosis.
Newberger DS
Am Fam Physician; 2000 Aug; 62(4):825-32, 837-8. PubMed ID: 10969860
[TBL] [Abstract][Full Text] [Related]
15. Comparison of urinary hyperglycosylated human chorionic gonadotropin concentration with the serum triple screen for Down syndrome detection in high-risk pregnancies.
Bahado-Singh RO; Oz U; Shahabi S; Mahoney MJ; Baumgarten A; Cole LA
Am J Obstet Gynecol; 2000 Nov; 183(5):1114-8. PubMed ID: 11084551
[TBL] [Abstract][Full Text] [Related]
16. [The prenatal diagnosis of Down's syndrome based on the biochemical screening of maternal serum markers].
Arbuzova SB; Nikolenko MI; Khlevnaia LA; Fedotova OO; Solov'eva VD; Malova SA
Tsitol Genet; 1998; 32(1):66-71. PubMed ID: 9695254
[TBL] [Abstract][Full Text] [Related]
17. Experience on triple markers serum screening for Down's syndrome fetus in Hat Yai, Regional Hospital.
Lamlertkittikul S; Chandeying V
J Med Assoc Thai; 2007 Oct; 90(10):1970-6. PubMed ID: 18041410
[TBL] [Abstract][Full Text] [Related]
18. Cutis marmorata telangiectatica congenita associated with an elevated maternal serum human chorionic gonadotrophin level and transitory isolated fetal ascites.
Chen CP; Chen HC; Liu FF; Jan SW; Chern SR; Wang TY; Hung HY
Br J Dermatol; 1997 Feb; 136(2):267-71. PubMed ID: 9068748
[TBL] [Abstract][Full Text] [Related]
19. Prenatal diagnosis and molecular cytogenetic characterization of a de novo interstitial duplication of 11q (11q22.3→q23.3) associated with abnormal maternal serum biochemistry.
Chen CP; Su YN; Lin SP; Chern SR; Su JW; Chen YT; Lee MS; Wang W
Taiwan J Obstet Gynecol; 2013 Mar; 52(1):120-4. PubMed ID: 23548232
[TBL] [Abstract][Full Text] [Related]
20. Molecular characterisation of a prenatally diagnosed 5q15q21.3 deletion and review of the literature.
Malan V; Martinovic J; Sanlaville D; Caillat S; Waill MC; Ganne ML; Tantau J; Attie-Bitach T; Vekemans M; Morichon-Delvallez N
Prenat Diagn; 2006 Mar; 26(3):231-8. PubMed ID: 16450350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
